Skip to main content
FDA approves new myasthenia gravis drug
Primary tabs
•••
View
Get Stamp Tags
Published Locations
Breadcrumb
Home
FDA approves new myasthenia gravis drug
User login
Username
Password
Reset your password
Concept
Lead
score
Myasthenia Gravis
1
1
Muscular Atrophy
0
0.89
Immunoglobulin G (IgG)
0
0.55
Rare Diseases
0
0.44
Receptors
0
0.44
Food and Drug Administration (FDA)
0
0.99
Skeletal Myoblasts
0
0.27
Muscle
0
0.22
Quality of Life
0
0.22
Biologic Therapy
0
0.12
Patient Safety
0
0.12
Adverse Effects
0
0.11
Grant
0
0.11
Orphan Drugs
0
0.11
Pathogenesis
0
0.11
Skeletal
0
0.11
Targeted Cancer Therapy
0
0.11
Weakness
0
0.11
Specialty
Lead
score
Neurology & Neurosurgery
1
1
Rheumatology
0
0.9
Internal Medicine
0
0.8
Pharmacist
0
0.6
Family Medicine/Primary Care
0
0.7